PERKINELMER INC (PKI) Stock Price, Forecast & Analysis
NYSE:PKI • US7140461093
PKI Key Statistics, Chart & Performance
The current stock price of PKI is 115.24 USD. In the past month the price decreased by -15.23%. In the past year, price decreased by -21.46%.
PKI Technical Analysis
PKI Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to PKI. The financial health of PKI is average, but there are quite some concerns on its profitability.
PKI Financial Highlights
Over the last trailing twelve months PKI reported a non-GAAP Earnings per Share(EPS) of 7.94. The EPS decreased by -30.47% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 16.32% | ||
| ROA | 5.28% | ||
| ROE | 10.11% | ||
| Debt/Equity | 0.53 |
PKI Forecast & Estimates
20 analysts have analysed PKI and the average price target is 159.39 USD. This implies a price increase of 38.31% is expected in the next year compared to the current price of 115.24.
For the next year, analysts expect an EPS growth of -34.36% and a revenue growth -31.32% for PKI
PKI Ownership
PKI Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 20.58 | 191.962B | ||
| DHR | DANAHER CORP | 24.67 | 148.096B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 139.57 | 46.374B | ||
| A | AGILENT TECHNOLOGIES INC | 20.3 | 34.761B | ||
| IQV | IQVIA HOLDINGS INC | 12.66 | 28.089B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 29.8 | 28.006B | ||
| WAT | WATERS CORP | 23.04 | 19.843B | ||
| ILMN | ILLUMINA INC | 22.73 | 17.98B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 30.72 | 17.346B | ||
| MEDP | MEDPACE HOLDINGS INC | 26.99 | 12.783B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About PKI
Company Profile
PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. The company is headquartered in Waltham, Massachusetts and currently employs 16,700 full-time employees. The firm operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides products and services targeted towards the life sciences and applied markets. The Diagnostics segment develops diagnostics, tools and applications focused on clinically oriented customers, especially within the reproductive health, immunodiagnostics and applied genomics markets. Its products and services for Discovery & Analytical Solutions applications include The Opera Phenix Plus high-content screening system, The Operetta CLS high-content analysis system, The MuviCyte live-cell imaging system, and The Signals Image Artist. Its products and services for Diagnostics applications include The DELFIA Xpress screening platform, The Specimen Gate informatics data management solution and The DELFIA Xpress sFlt-1 kit.
Company Info
PERKINELMER INC
940 Winter Street
Waltham MASSACHUSETTS 02451 US
CEO: Prahlad Singh
Employees: 16700
Phone: 17816635776.0
PERKINELMER INC / PKI FAQ
What does PERKINELMER INC do?
PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. The company is headquartered in Waltham, Massachusetts and currently employs 16,700 full-time employees. The firm operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides products and services targeted towards the life sciences and applied markets. The Diagnostics segment develops diagnostics, tools and applications focused on clinically oriented customers, especially within the reproductive health, immunodiagnostics and applied genomics markets. Its products and services for Discovery & Analytical Solutions applications include The Opera Phenix Plus high-content screening system, The Operetta CLS high-content analysis system, The MuviCyte live-cell imaging system, and The Signals Image Artist. Its products and services for Diagnostics applications include The DELFIA Xpress screening platform, The Specimen Gate informatics data management solution and The DELFIA Xpress sFlt-1 kit.
What is the stock price of PERKINELMER INC today?
The current stock price of PKI is 115.24 USD. The price decreased by -0.91% in the last trading session.
What is the dividend status of PERKINELMER INC?
PKI does not pay a dividend.
How is the ChartMill rating for PERKINELMER INC?
PKI has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
What is the ex-dividend date for PKI stock?
The next ex-dividend date for PERKINELMER INC (PKI) is July 20, 2023.
What is the next earnings date for PKI stock?
PERKINELMER INC (PKI) will report earnings on 2023-07-31, before the market open.
Who owns PERKINELMER INC?
You can find the ownership structure of PERKINELMER INC (PKI) on the Ownership tab.